|
|
||||||||
1 Department of Pathology and 2 Department of Medicine, University of California San Diego, La Jolla, California 92093; and 3 Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710
The protein phosphatase 2A (PP2A)
holoenzyme consists of a catalytic subunit, C, and two regulatory
subunits, A and B. The PP2A core enzyme is composed of subunits A and
C. Both the holoenzyme and the core enzyme are similarly abundant in
heart tissue. Transgenic mice were generated expressing high levels of
a dominant negative mutant of the A subunit (A
5) in the heart,
skeletal muscle, and smooth muscle that competes with the endogenous A
subunit for binding the C subunit but does not bind B subunits. We
found that the ratio of core enzyme to holoenzyme was increased in
A
5-expressing hearts. Importantly, already at day 1 after
birth, A
5-transgenic mice had an increased heart weight-to-body
weight ratio that persisted throughout life. Echocardiographic analysis
of A
5-transgenic hearts revealed increased end-diastolic and
end-systolic dimensions and decreased fractional shortening. In
addition, the thickness of the septum and of the left ventricular
posterior wall was significantly reduced. On the basis of these
findings, we consider the heart phenotype of A
5-transgenic mice to
be a form of dilated cardiomyopathy that frequently leads to premature death.
protein phosphatase 2A holoenzyme; protein phosphatase 2A core enzyme; heart weight-to-body weight ratio; muscle-specific gene expression
This article has been cited by other articles:
![]() |
N. Bhasin, S. R. Cunha, M. Mudannayake, M. S. Gigena, T. B. Rogers, and P. J. Mohler Molecular basis for PP2A regulatory subunit B56{alpha} targeting in cardiomyocytes Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H109 - H119. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Glaser, Y. O. Lukyanenko, Y. Wang, G. M. Wilson, and T. B. Rogers JNK activation decreases PP2A regulatory subunit B56{alpha} expression and mRNA stability and increases AUF1 expression in cardiomyocytes Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1183 - H1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-K. Kim, J. Suarez, Y. Hu, P. M. McDonough, C. Boer, D. J. Dix, and W. H. Dillmann Deletion of the Inducible 70-kDa Heat Shock Protein Genes in Mice Impairs Cardiac Contractile Function and Calcium Handling Associated With Hypertrophy Circulation, June 6, 2006; 113(22): 2589 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Carr, A. G. Schmidt, Y. Suzuki, F. del Monte, Y. Sato, C. Lanner, K. Breeden, S.-L. Jing, P. B. Allen, P. Greengard, et al. Type 1 Phosphatase, a Negative Regulator of Cardiac Function Mol. Cell. Biol., June 15, 2002; 22(12): 4124 - 4135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kapiloff, N. Jackson, and N. Airhart mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope J. Cell Sci., January 9, 2001; 114(17): 3167 - 3176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kins, A. Crameri, D. R. H. Evans, B. A. Hemmings, R. M. Nitsch, and J. Gotz Reduced Protein Phosphatase 2A Activity Induces Hyperphosphorylation and Altered Compartmentalization of Tau in Transgenic Mice J. Biol. Chem., October 5, 2001; 276(41): 38193 - 38200. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zhang, E. N. Johnson, Y. Gu, M. R. Morissette, V. P. Sah, M. S. Gigena, D. D. Belke, W. H. Dillmann, T. B. Rogers, H. Schulman, et al. The Cardiac-specific Nuclear delta B Isoform of Ca2+/Calmodulin-dependent Protein Kinase II Induces Hypertrophy and Dilated Cardiomyopathy Associated with Increased Protein Phosphatase 2A Activity J. Biol. Chem., January 4, 2002; 277(2): 1261 - 1267. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |